How Partnerships are Shaping Pharma R&D

By: Janifha Evangeline, Assistant Editor, India Pharma Outlook

Isomorphic Labs, on the 7th of January this year announced that it has entered into strategic partnerships with Eli Lilly

Top Innovations in Drug Delivery Systems

By: Janifha Evangeline, Assistant Editor, India Pharma Outlook

Kindeva Drug Delivery’s Woodbury, Minnesota facility that was launched earlier in 2024 was inspected & has been classified by the FDA successfully

Adopting AI and Machine Learning in Indian Pharma R&D

By: Rejith P R, Correspondent, India Pharma Outlook

EY Parthenon published a report titled 'From Volume to Value: Indian Pharma's Transformation with Data and AI' in partnership with the Government of Telangana at the BioAsia 2024. The report stressed the potential of how Generative AI can redefine...

Accelerating Time-to-Market: Leveraging India's Clinical Trial Capabilities

By: Hridkamal Roy, Assistant Managing Editor, India Pharma Outlook

India has risen as a pivotal contributor in this arena, providing distinct benefits that can be utilized to fast-track the creation and sanctioning of novel treatments.

Role of Data in Advancing Personalized Medicine for Animals

By: Hridkamal Roy, Assistant Managing Editor, India Pharma Outlook

The approach of precision medicine is designed for healthcare customization, with treatments being specifically designed to match the distinct genetic makeup, habits, and environmental exposures of each patient

Achieving NABH Accreditation: Best Practices for Healthcare Providers

By: Darshan.K, Assistant Editor, India Pharma Outlook

As of 2023, over 800 hospitals in India have achieved NABH accreditation, reflecting a growing emphasis on quality healthcare. NABH accreditation is not just a prestigious certification but a comprehensive framework designed to enhance patient...

© 2024 India Pharma Outlook. All Rights Reserved.